Singapore: Sydney-based biotechnology firm, NeuClone has signed a major licensing agreement and joint development partne...
Singapore: Novartis India has over the past year launched three successful patented drugs and over 12 generic drugs. The...
Hyderabad: BioAsia 2013, which was held recently from January 28-30, 2013, at Hyderabad, India, saw participation from 5...
Singapore: United States Federal Drug Approval (USFDA) has issued a letter to the COO of Apotex Mr Jeremy B Desai. Th le...
Singapore: Fortis Healthcare has come up with its vision for the next generation hospital, the 'Fortis Memorial Researc...
New Delhi: The IMS Health Total Sales Audit (TSA) has released a report stating that the Indian pharmaceutical market ha...
Singapore: In a press conference announcing a second successful experimental minimally invasive cardiovascular bypass su...
Singapore: India based contract research organization (CRO), Cliantha Research has implemented Acceliant's eClinical Sui...
Singapore: According to Merck's press release, the facilities at the lab were built to provide services and application ...
New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and eff...
Singapore: "At least 41 people, including 31 children, have died and more than 22,000 have fallen ill since the first we...
Singapore: Dr. Reddy's Laboratories and Merck Serono, a division of Merck KGaA, Darmstadt, Germany, have entered into a ...
Singapore: Biological E has entered into a long term supply agreement with Vacsera (and its subsidiary Egyvac), an Egypt...
Singapore: Merely a month after Indian drug major, Ranbaxy, pleaded guilty of having misled the USFDA investigations, se...
India emerged as the second largest country in terms of the total revenue generated by companies during the calendar yea...
New Delhi: A group of scientists at the directorate of Cold Water Fisheries Research, Bhimtal, led by Dr Ashoktaru Barat...
Mumbai: The Council of Scientific and Industrial Research (CSIR), India, under its New Millennium Indian Technology Lead...
Mumbai: The Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organiza...
